Unmet Needs in Parkinson's Disease.

Movement Disorders Clinical PracticeVolume 10, Issue S2 p. S47-S49 EDITORIAL COMMENTARY Unmet Needs in Parkinson's Disease Susan H. Fox MD, PhD, Corresponding Author Susan H. Fox MD, PhD [email protected] Movement Disorder Clinic, Edmond J. Safra Program in Parkinson's Disease, Division of Neurology, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada Correspondence to: Dr. Susan Fox, Movement Disorder Clinic, Toronto Western Hospital, 399, Bathurst St, Toronto ON, M5T 2S8, Canada; E-mail: [email protected]Search for more papers by this authorFrancisco Cardoso MD, PhD, Francisco Cardoso MD, PhD orcid.org/0000-0003-0808-0116 The Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this author Susan H. Fox MD, PhD, Corresponding Author Susan H. Fox MD, PhD [email protected] Movement Disorder Clinic, Edmond J. Safra Program in Parkinson's Disease, Division of Neurology, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada Correspondence to: Dr. Susan Fox, Movement Disorder Clinic, Toronto Western Hospital, 399, Bathurst St, Toronto ON, M5T 2S8, Canada; E-mail: [email protected]Search for more papers by this authorFrancisco Cardoso MD, PhD, Francisco Cardoso MD, PhD orcid.org/0000-0003-0808-0116 The Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this author First published: 23 August 2023 https://doi.org/10.1002/mdc3.13838 Relevant disclosures and conflicts of interest are listed at the end of this article. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Antonini A, Emmi A, Campagnolo M. Beyond the dopaminergic system: lessons learned from L-Dopa resistant symptoms in Parkinson's disease. Mov Disord Clin Pract 2023; 10(S2): S50–S55. https://doi.org/10.1002/mdc3.13786. 2Tosserams A, Bloem BR, Nonnekes J. Compensation strategies for gait impairments in Parkinson's disease: from underlying mechanisms to daily clinical practice. Mov Disord Clin Pract 2023; 10(S2): S56–S62. https://doi.org/10.1002/mdc3.13616. 3Hvisdak V, Huang AP, Kluger BM. Palliative care of end stage parkinsonism: an overview including the five pillars framework. Mov Disord Clin Pract 2023; 10(S2): S63–S67. https://doi.org/10.1002/mdc3.13620. 4Miyasaki JM, Lim SY, Chaudhuri KR, et al. Access and attitudes toward palliative care among movement disorders clinicians. Mov Disord 2022; 37: 182–189. 5Corcoran J, Huang AH, Miyasaki JM, Tarolli CG. Palliative care in Parkinson disease and related disorders. Handb Clin Neurol 2023; 191: 107–128. 6https://www.movementdisorders.org/MDS/About/Committees--Other-Groups/MDS-Study-Groups/Palliative-Study-Group.htm. Accessed on 6.2.2023. 7Jha A, Espay AJ, Lees AJ. Digital biomarkers in Parkinson's disease: missing the forest for the trees? Mov Disord Clin Pract 2023; 10(S2): S68–S72. https://doi.org/10.1002/mdc3.13746. 8Lipsmeier F, Taylor KI, Postuma RB, et al. Reliability and validity of the Roche PD Mobile application for remote monitoring of early Parkinson's disease. Sci Rep 2022; 12: 1–15. 9https://www.fda.gov/science-research/focus-areas-regulatory-science-report/focus-area-patient-reported-outcomes-and-other-clinical-outcome-assessments. Accessed on 6.2.2023. Volume10, IssueS2Supplement: 1st MDCP Conference: Unanswered Questions and Unmet Clinical Needs in Movement Disorders London, United KingdomAugust 2023Pages S47-S49 ReferencesRelatedInformation